Armata Pharmaceuticals is a publicly traded company whose common shares are listed on the NYSE American stock exchange under the ticker symbol ARMP. As a publicly registered entity, the company is subject to regulatory filing requirements with the Securities and Exchange Commission, issuing regular quarterly financial reports, updates on clinical stage synthetic bacteriophage trials, and annual shareholder meeting notifications for public market investors.